Stockreport

Plus Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

PLUS THERAPEUTICS, Inc.  (PSTV) 
PDF AUSTIN, Texas, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a clinical-stage pharmaceutical company developing [Read more]